PRINCETON, N.J., Aug. 29, 2023 — Certara, Inc. バイオシミュレーションのグローバルリーダーであるサターラ（Nasdaq：CERT) はCERT), a global leader in biosimulation, today announced that Company management will participate in the following investor conferences:
- Morgan Stanley 21st Annual Global Healthcare Conference
Date and Time: Tuesday, September 12 at 5:30 p.m. ET - Baird Global Healthcare Conference
Date and Time: Wednesday, September 13 at 3:45 p.m. ET
Live webcasts for each of the conferences will be available on Certara’s investor relations website at
https://ir.certara.com and will be available for replay for at least 90 days thereafter.
Certara（サターラ）について
Certara accelerates medicines using proprietary biosimulation software, technologyand services to transform traditional drug discovery and development. Its clientsinclude more than 2,300 biopharmaceutical companies, academic institutions, andregulatory agencies across 70 countries.
投資家の皆様：
David Deuchler
Gilmartin Group
ir@certara.com
報道機関の皆様：
赤津笑美 emi.akatsu@certara.com
サターラ合同会社
daniel.yunger@kekstcnc.com
